Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for treating malaria

A technology for treating malaria and a composition, applied in the field of pharmacy, can solve the problem of no cure for malaria, and achieve the effects of increasing blood supply to the brain, prolonging survival time, and improving drug bioavailability

Active Publication Date: 2018-05-29
INST OF CHINESE MATERIA MEDICA CHINA ACAD OF CHINESE MEDICAL SCI
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Once malaria parasites develop resistance to current ACTs on a large scale, malaria will face the dilemma of no cure, and the development of new compound antimalarial drugs will face major challenges

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition for treating malaria
  • Medicine composition for treating malaria
  • Medicine composition for treating malaria

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0132] Embodiment 1, pharmaceutical composition of the present invention

[0133] Artesunate 40mg, ligustrazine hydrochloride 20mg

[0134] (1) Take 40mg artesunate, add 1ml 0.9% sodium chloride injection, dissolve completely, then add 3ml 0.9% sodium chloride injection to dilute,

[0135] (2) Take 20mg ligustrazine hydrochloride, add 4ml of 0.9% sodium chloride injection and shake until completely dissolved,

[0136] (3) Mix the solutions obtained in the above two steps evenly.

Embodiment 2

[0137] Embodiment 2, pharmaceutical composition of the present invention

[0138] Artesunate 20mg, ligustrazine hydrochloride 20mg

[0139] (1) Take 20mg artesunate, add 1ml 0.9% sodium chloride injection, dissolve completely, then add 1ml 0.9% sodium chloride injection to dilute,

[0140] (2) Take 20mg ligustrazine hydrochloride, add 4ml of 0.9% sodium chloride injection and shake until completely dissolved,

[0141] (3) Mix the solutions obtained in the above two steps evenly.

Embodiment 3

[0142] Embodiment 3, pharmaceutical composition of the present invention

[0143] Artesunate 20mg, ligustrazine hydrochloride 40mg

[0144] (1) Take 20mg artesunate, add 1ml 0.9% sodium chloride injection, dissolve completely, then add 1ml 0.9% sodium chloride injection to dilute,

[0145] (2) Take 40mg ligustrazine hydrochloride, add 8ml of 0.9% sodium chloride injection and shake until completely dissolved,

[0146] (3) Mix the solutions obtained in the above two steps evenly.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of pharmaceutical science, and relates to a traditional Chinese medicine composition, in particular to a medicine composition for treating malaria. The medicine composition disclosed by the invention has the characteristics of good curative effect, quick effect, stable quality and capability of relieving nerve injury symptoms. The medicine composition disclosed by the invention is prepared from artesunate and ligustrazine or medicinal salt thereof, and the weight ratio of which is (1 to 10):(10 to 1).

Description

technical field [0001] The invention belongs to the field of pharmacy and relates to a traditional Chinese medicine composition, in particular to a medicinal composition for treating malaria. Background technique [0002] Malaria is a major infectious disease that seriously threatens human health and life safety. It spreads and prevails in 108 countries and regions around the world. About half of the world's population is threatened by malaria. It is one of the three major public health problems in the world. According to WHO's 2016 World Malaria Report, about 3.2 billion people (accounting for nearly half of the world's total population) are at risk of malaria. In 2015, there were 214 million new cases of malaria, and about 438,000 people died of malaria. At the same time, the drug resistance of Plasmodium also poses a serious challenge to malaria drug treatment. In order to improve clinical efficacy and delay the emergence of drug resistance, WHO has promoted artemisinin-...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/4965A61K9/08A61P33/06A61P25/00A61P9/10A61K31/357
CPCA61K47/02A61K9/0043A61K9/08A61K31/357A61K31/4965A61K2300/00A61K9/127A61P33/06Y02A50/30
Inventor 朱晓新李玉洁陈利娜蔡维艳翁小刚谷丽维杨庆李凯姜晓慧郭媛
Owner INST OF CHINESE MATERIA MEDICA CHINA ACAD OF CHINESE MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products